Metoprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in hypertension, ischaemic heart disease and related cardiovascular disorders.

Metoprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in hypertension, ischaemic heart disease and related cardiovascular disorders.

Item
http://www.wikidata.org/entity/Q39478484
Metoprolol CR/XL in the treatment of chronic heart failure.CNS-related performance and haemodynamics of metoprolol-Oros and propranolol after single and 3 days dosing in healthy volunteers.Extended-release metoprolol succinate in chronic heart failure.The use of metoprolol CR/XL in the treatment of patients with diabetes and chronic heart failure.Ophthalmic drug design based on the metabolic activity of the eye: soft drugs and chemical delivery systems.Pharmacokinetic and biopharmaceutic aspects of once daily treatment with metoprolol CR/ZOK: a review article.Tolerability and well-being with metoprolol in a controlled release (CR/ZOK) formulation: a review article.Advances in the use of prodrugs for drug delivery to the eye.Pharmacokinetic Variability of Drugs Used for Prophylactic Treatment of Migraine.{2-Hydr-oxy-3-[4-(2-methoxy-ethyl)-phen-oxy]prop-yl}isopropyl-ammonium hemisuccinate.Reduction (TELMAR) as assessed by magnetic resonance imaging in patients with mild-to-moderate hypertension--a prospective, randomised, double-blind comparison of telmisartan with metoprolol over a period of six months rationale and study design.Metoprolol oxidation polymorphism in Brazilian elderly cardiac patients.Effects of 100 mg of controlled-release metoprolol and 100 mg of atenolol on blood pressure, central nervous system-related symptoms, and general well being.Metoprolol decreases the plasma exposure of metformin via the induction of liver, kidney and muscle uptake in rats.Correlation of pharmacological properties of a group of beta-blocker agents by molecular topology.
P2860

Metoprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in hypertension, ischaemic heart disease and related cardiovascular disorders.

Item
http://www.wikidata.org/entity/Q39478484
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh
1986年學術文章
@zh-hant
name
Metoprolol. An updated review ...... ated cardiovascular disorders.
@en
Metoprolol. An updated review ...... ated cardiovascular disorders.
@nl
type
label
Metoprolol. An updated review ...... ated cardiovascular disorders.
@en
Metoprolol. An updated review ...... ated cardiovascular disorders.
@nl
prefLabel
Metoprolol. An updated review ...... ated cardiovascular disorders.
@en
Metoprolol. An updated review ...... ated cardiovascular disorders.
@nl
P1433
P1476
P2093
P2888
P304
P31
P356
P433
P478
P50
P577
P6179
P698
P921
P356
P1433
P1476
Metoprolol. An updated review ...... ated cardiovascular disorders.
@en
P2093
P2888
P304
P31
P356
10.2165/00003495-198631050-00002
P433
P478
P50
P577
P6179
P698
P921